Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term heterogeneity. Found 12 abstracts

Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshaysky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in oncology. 2019 Jan;8:652.   PMCID: PMC6344461
Dias MF, Blumenstein R, Russo J. Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancer. Oncology Letters. 2017 May;13(5):3831-6.   PMCID: PMC5431386
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescut DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 Jul;103(30):11154-9.
Larson GP, Ding Y, Cheng LS, Lundberg C, Gagalang V, Rivas G, Geller L, Weitzel J, MacDonald D, Archambeau J, Slater J, Neuberg D, Daly MB, Angel I, Benson AB, Smith K, Kirkwood JM, O'Dwyer PJ, Raskay B, Sutphen R, Drew R, Stewart JA, Werndli J, Johnson D, Ruckdeschel JC, Elston RC, Krontiris TG. Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT. Cancer Research. 2005 Feb;65(3):805-14.
Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, Runnebaum IB. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer. 1999 Sep;81(1):179-83.
Gulati S, Baker P, Li YN, Fowler B, Kruger W, Brody LC, Banerjee R. Defects in human methionine synthase in cblG patients. Human molecular genetics. 1996 Dec;5(12):1859-65.
Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma. Molecular Carcinogenesis. 1996 Nov;17(3):117-25.
Bianchi AB, Hara T, Ramesh V, Gao JZ, Kleinszanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N. Mutations in Transcript Isoforms of the Neurofibromatosis-2 Gene in Multiple Human Tumor Types. Nature genetics. 1994 Feb;6(2):185-92.
Jeneson JA, Vandobbenburgh JO, Vanechteld CJ, Lekkerkerk C, Janssen WJ, Dorland L, Berger R, Brown TR. Experimental-Design of P-31 Mrs Assessment of Human Forearm Muscle Function - Restrictions Imposed by Functional-Anatomy. Magnetic Resonance in Medicine. 1993 Nov;30(5):634-40.
Loftus SK, Edwards SJ, Scherpbierheddema T, Buetow KH, Wasmuth JJ, Dixon MJ. A Combined Genetic and Radiation Hybrid Map Surrounding the Treacher-Collins Syndrome Locus on Chromosome-5q. Human molecular genetics. 1993 Nov;2(11):1785-92.
Mills KA, Buetow KH, Xu Y, Weber JL, Altherr MR, Wasmuth JJ, Murray JC. Genetic and Physical Maps of Human Chromosome-4 Based on Dinucleotide Repeats. Genomics. 1992 Oct;14(2):209-19.
Yang P, Beaty TH, Khoury MJ, Chee E, Stewart W, Gordis L. Genetic-Epidemiologic Study of Omphalocele and Gastroschisis - Evidence for Heterogeneity. American Journal of Medical Genetics. 1992 Nov 15;44(5):668-75.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term heterogeneity

heterogeneity expression human genome polymerase chain-reaction breast-cancer carcinoma susceptibility polymorphisms locus multilocus linkage analysis congenital heart-disease molecular target identification cobalamin statistics hybridization dinucleotide repeat polymorphism oxidoreductase births precision oncology germline mutations carcinogen metabolism epithelial-cells ductal carcinoma loss of heterozygosity assay retinoblastoma tandem bilateral acoustic neurofibromatosis metaanalysis breast cancer deficiency in-vivo growth-factor huntington disease gene breast cancer-resistance protein 1 cfdna pairs binding regions fetal omphalocele somatic mutation molecular analysis Multidisciplinary Sciences dna polymorphisms exercise linkage nf2 p53 in-situ tumor burden allelic loss magnetic-resonance spectroscopy BRCA2 complex traits survival liquid biopsy evolution gastroschisis localization long arm growth human tumors region genetic genetic susceptibility etiologic genetic heterogeneity washington families paclitaxel multidrug-resistance drug efflux capacity cancer phosphorus magnetic resonance spectroscopy samples chromosome-22 human mitochondrial myopathies colorectal-cancer DNA family drug resistance markers cleft-lip genetic epidemiology breast neoplasms BRCA1 metabolism mutation ovarian cancer nmr-spectroscopy escherichia-coli heterozygosity malformations neural-tube defects tumor heterogeneity omphalocele skeletal muscle allele loss recombination chromosome-17 laser microdissection metastasis polyposis cdkn2 gene palate anatomy haplotypes construction dna chromosome 9p tp53 polymorphism cancer stem cells
Last updated on Wednesday, March 04, 2020